- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
High Tide
Market Cap: CA$297.8m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.38
7D
7.0%
1Y
-6.1%
Verano Holdings
Market Cap: CA$526.7m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.45
7D
2.8%
1Y
16.9%
Curaleaf Holdings
Market Cap: CA$2.5b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$3.05
7D
-7.9%
1Y
54.8%
Trulieve Cannabis
Market Cap: CA$1.4b
Operates as a cannabis retailer.
TRUL
CA$8.20
7D
-5.4%
1Y
34.0%
Medexus Pharmaceuticals
Market Cap: CA$93.3m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.84
7D
-0.7%
1Y
-4.7%
Cresco Labs
Market Cap: CA$588.9m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.30
7D
-5.8%
1Y
1.6%
TerrAscend
Market Cap: CA$289.2m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.78
7D
-6.0%
1Y
-1.3%
Aurora Cannabis
Market Cap: CA$290.9m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$5.03
7D
3.3%
1Y
-37.4%
Organigram Global
Market Cap: CA$264.9m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.95
7D
12.1%
1Y
11.4%